Translation of "Directive 7 de l'ICA " (French → English) :

Definition: This block contains a wide variety of disorders that differ in severity and clinical form but that are all attributable to the use of one or more psychoactive substances, which may or may not have been medically prescribed. The third character of the code identifies the substance involved, and the fourth character specifies the clinical state. The codes should be used, as required, for each substance specified, but it should be noted that not all fourth character codes are applicable to all substances. Identification of the psychoactive substance should be based on as many sources of information as possible. These include sel ...[+++]f-report data, analysis of blood and other body fluids, characteristic physical and psychological symptoms, clinical signs and behaviour, and other evidence such as a drug being in the patient's possession or reports from informed third parties. Many drug users take more than one type of psychoactive substance. The main diagnosis should be classified, whenever possible, according to the substance or class of substances that has caused or contributed most to the presenting clinical syndrome. Other diagnoses should be coded when other psychoactive substances have been taken in intoxicating amounts (common fourth character .0) or to the extent of causing harm (common fourth character .1), dependence (common fourth character .2) or other disorders (common fourth character .3-.9). Only in cases in which patterns of psychoactive substance-taking are chaotic and indiscriminate, or in which the contributions of different psychoactive substances are inextricably mixed, should the diagnosis of disorders resulting from multiple drug use (F19.-) be used. | Modifiers The following fourth-character subdivisions are for use with categories F10-F19: Code Title .0 Acute intoxication A condition that follows the administration of a psychoactive substance resulting in disturbances in level of consciousness, cognition, perception, affect or behaviour, o ...

directive (EU) [ Commission Directive | Community directive | Council Directive | European Parliament and Council directive ]

lineal descent

implementing directive [ Commission implementing directive | Council implementing directive ]

national implementing measure [ implementation of EC Directives | transposition of European directives ]

Definition: A disorder characterized by impairment of memory, learning difficulties, and reduced ability to concentrate on a task for more than brief periods. There is often a marked feeling of mental fatigue when mental tasks are attempted, and new learning is found to be subjectively difficult even when objectively successful. None of these symptoms is so severe that a diagnosis of either dementia (F00-F03) or delirium (F05.-) can be made. This diagnosis should be made only in association with a specified physical disorder, and should not be made in the presence of any of the mental or behavioural disorders classified to F10-F99. The disorder may precede, accompany, or follow a wide variety of infections and physical disorders, both cerebral and syst ...[+++]emic, but direct evidence of cerebral involvement is not necessarily present. It can be differentiated from postencephalitic syndrome (F07.1) and postconcussional syndrome (F07.2) by its different etiology, more restricted range of generally milder symptoms, and usually shorter duration.

endemic conditions associated with environmental iodine deficiency either directly or as a consequence of maternal iodine deficiency. Some of the conditions have no current hypothyroidism but are the consequence of inadequate thyroid hormone secretion in the developing fetus. Environmental goitrogens may be associated.

tetrasodium 3,3'-[biphenyl-4,4'-diylbis(diazenediyl)]bis(5-amino-4-hydroxynaphthalene-2,7-disulfonate) [ Direct Blue 2B | Direct Blue BB | Direct Blue K | Direct Blue 6 | direct blue 6 | tetrasodium salt of 3,3'-[4,4'-biphenylylene) bis(azo]bis(5-amino-4-hydroxy-2,7-naphthalenedisulfonic acid | sodium diphenyl-4,4'-bis-azo-2'-8'-amino-1'-naphthol-3',6'-disulphonate ]

disodium 4-amino-3-({4'-[(2,4-diaminophenyl)diazenyl]biphenyl-4-yl}diazenyl)-5-hydroxy-6-(phenyldiazenyl)naphthalene-2,7-disulfonate [ Direct Black Meta | direct black meta ]

infringement of Article 8 of Regulation No 40/94 and failure to provide adequate reasons as regards the similarity between the goods deriving from San Lucio milk and the goods covered by the registration of ICA’s marks;

infringement of the Article 8 of Regulation No 40/94 and failure to provide adequate reasons as regards the similarity between the mark GROK of San Lucio and the mark CRIK CROK of ICA;

Applicant: Ica Foods SpA (Pomezia, Italy) (represented by: A. Nespega, lawyer)

Financial Services || Action plan for Financial Services and follow-ups (Directive 2006/43/EC, Directive 2006/46/EC, Directive 2007/63/EC, Directive 2007/44/EC, Directive 2009/14/EC, Directive 2007/36/EC, Directive 2007/64/EC, Directive 009/111/EC, Directive 2009/44/EC, Directive2010/76/EU, Directive 2009/49/EC, Directive 2011/61/EU, Directive 2011/89/EU)